Silexion Therapeutics Corporation (SLXN) 銘柄情報

Flying again AH 
5$

Ty🤑👍

🤑🤑🤑🤑🤑

SLXN........................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

SLXN: Humanoids?? Heck, Robotoids are good enough for this Wall Street Suckers Bait!!!

Rats on clinical trial probably not ...all out $1.40s give me some humanoids for $5s $20s lol

SLXN: See its real-time 'CHART', below --- right now!!!

SLXN: Merely a classic PRE-Clinical Cancer cure in a Petri Dish --- and not even a REAL Petri DIsh --- just a DIGITAL MODEL of one, in a cheap computer??? But, watch it fly to $5.00+ anyway!!!

Halt at $1.40 resume at 9:38 so will sell out of most shares likely 

SLXN................................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

SLXN: (Was in SHOWER over here, & my new "Tw0122-Stock-Alert-Alarm" went off!!!) O.K., so SLXN has a Pre-Clinical Cancer cure!! LOVE-IT!!

SLXN $1.24

SLXN $1.13 next zone $1.56

News party back .98 + 70%

.777

SLXN: Whelp, no 'party' atmosphere over here either --- now I know how those 10,000+ homes & business owners over in L.A. County, CA, feel right now.

LOL welcome to federal "pound me in the ass" prison. This terd is going under $1.00 and then R/S, then BK.

Tomorrow probably open @ $1.50

👿FFER AT THE CLOSE https://x.com/THIS_TIME_X/status/1879696402051445017

slxn...........................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

https://www.globenewswire.com/news-release/2025/01/15/3010424/0/en/Silexion-Therapeutics-Announces-Additional-Promising-Preclinical-Data-for-SIL-204-Demonstrating-Impressive-Synergy-with-First-Line-Pancreatic-Cancer-Chemotherapies.html

SLXN..............................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

Start watching again in $2s

slxn.........................https://stockcharts.com/h-sc/ui?s=sxln&p=W&b=5&g=0&id=p86431144783

SLXN, under $3

slxn..................................https://stockcharts.com/h-sc/ui?s=slxn&p=W&b=5&g=0&id=p86431144783

slxn............................https://stockcharts.com/h-sc/ui?s=slxn&p=W&b=5&g=0&id=p86431144783

SLXN...........................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

5.05 + 85% start cashing out most 

4.30 + 60%

Low float heaven $3,88 +'40% 

SLXN: Will do!!

Reverse split complete keep on watch 

Piece of shit red every day.

SLXN..........................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

SLXN: Soaring in the Pre-M right now, behind their Cancer stuff!!

SLXN, doing 1 for 10/20 Reverse Splits

We are holding this extraordinary general meeting to allow the Company’s board of directors to effect a reverse share split of the Company’s ordinary shares at a ratio of not less than 1-for-10 and not more than 1-for-20, with the exact ratio to be determined by the Company’s board of directors prior to the extraordinary general meeting and to be presented for approval by our shareholders at the meeting.

SLXN.....................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

Hit .96 resistance will dump from here as only mice animal study .. can inhibit the growth and induce necrosis of the human pancreatic cell line that bears the KRAS G12D mutation xenotransplanted into mice

Clinical phase 2/3 not until 2026

Silexion Therapeutics Reports Breakthroughs From SIL-204 Preclinical Studies

dumping as usual

SLXN..........................................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

$10- $12 just a couple month back in July on ipo then furiously dumped. Pump and then quick dump to fleece shareholders again is highly probable. Don’t stick around too long

Silexion Therapeutics Announces Significant New Data from Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer

SLXN..........................................https://stockcharts.com/h-sc/ui?s=SLXN&p=W&b=5&g=0&id=p86431144783

UNMITIGATED DUMPING now

Will certainly close red.

I guarantee it.

DUMPED all my $1zzz at $1.75

Gets above 2.26 then we get cooking rejects it then dumps

PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers

Silexion Therapeutics represents a unique approach in the fight against KRAS-driven cancers, particularly pancreatic cancer. Its innovative RNAi technology, delivered via the LODER™ platform and the promising SIL-204, seems to address many of the challenges that have historically limited progress in treating these aggressive cancers. As the company advances its clinical trials and potentially potential eyes other KRAS-driven cancers, it stands at the forefront of a new era in precision oncology.

While the road ahead in drug development is always challenging, Silexion's progress to date and the potential of its technology make it a company to watch in the evolving landscape of cancer treatment. As with any early-stage biotech company, potential stakeholders should conduct thorough due diligence, considering both the promising technology and market opportunity alongside the inherent risks in drug development.